Effects of rosuvastatin calcium on bone mineral density in patients with type 2 diabetes mellitus complicated with osteoporosis and carotid atherosclerotic plaque
10.3760/cma.j.issn.1008-6315.2017.08.009
- VernacularTitle:瑞舒伐他汀钙对2型糖尿病伴骨质疏松症患者骨密度及颈动脉硬化斑块的影响
- Author:
Jian WEI
- Keywords:
Rosuvastatin calcium;
Type 2 diabetes mellitus;
Osteoporosis;
Bone mineral density;
Adiponectin;
Carotid atherosclerotic plaques
- From:
Clinical Medicine of China
2017;33(8):705-709
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of rosuvastatin calcium on bone mineral density and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus complicated with osteoporosis.Methods Eighty-two T2DM patients with osteoporosis were randomly divided into two groups,41 cases in the treatment group and 41 cases in the control group.The control group received routine treatment,including insulin and Caltrate D treatment.The observation group was treated with rosuvastatin calcium 10 mg 1 time/d orally,on the basis of the routine treatmentv.The two groups were treated for 12 weeks.After treatment,the blood glucose level,bone mineral density and carotid atherosclerotic plaques were compared.Results After treatment,the levels of blood sugar,FBG ((7.2±0.4) mmol/L),2 hBG ((9.2±0.6) mmol/L),HbAlc ((7.2±0.4) mmol/L) in the observation groups were lower than those before treatment ((9.6±0.5) mmol/L,(12.3±0.6) mmol/L,(9.8±0.7) mmol/L,t=24.0,23.39,20.65,P<0.05),the levels of blood sugar,FBG,2 hBG,HbAlc in the control group were (8.4±0.3) mmol/L,(10.5±0.6) mmol/L and (8.3±0.6) mmol/L,lower than those before treatment ((9.3±0.3) mmol/L,(12.0±0.8) mmol/L,(9.9±0.5) mmol/L,t=13.58,9.60,13.12,P<0.05).The three indexes in the observation group were lower than those in the control group (t=-15.37,-9.8,-9.77,P<0.05).After 1 course of treatment,the femoral neck BMD value in the observation group was higher than that before treatment ((0.699±0.111) g/cm2 vs.(0.665±0.106) g/cm2,t=0.790,P<0.05),there was no significant increase in the BMD value in the control group after treatment ((0.669±0.130) g/cm2 vs.(0.662±0.119) g/cm2,t=-0.25,P>0.05),the BMD of femoral neck in the observation group after treatment was higher than that in the control group (t=0.842,P<0.05).After 1 course of treatment,IMT value and plaque score in the observation group were lower than those before treatment ((1.202±0.18) mm vs.(1.582±0.369) mm,(3.62±0.33) points vs.(4.39±0.37) points,t=0.778,9.945,P<0.05),in the control group,the intima-media thickness of the carotid artery and plaque score after treatment were not significantly increased compared with those before treatment ((1.487±0.345) mm vs.(1.499±0.356) mm,(4.16±0.26) points vs.(4.28±0.28) mm,t=0.155,2.011,P>0.05).The differences between the observation group and the control group after treatment were statistically significant (t=0.534,0.645,P<0.05).Conclusion Rosuvastatin calcium can effectively improve the curative effect of type 2 diabetes mellitus in patients with osteoporosis and improve bone mineral density and carotid atherosclerotic plaques.
